{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T20:17:06Z","timestamp":1789503426045,"version":"build-2803163510"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,6,12]],"date-time":"2019-06-12T00:00:00Z","timestamp":1560297600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.01349","type":"journal-article","created":{"date-parts":[[2019,6,12]],"date-time":"2019-06-12T14:22:57Z","timestamp":1560349377000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":31,"title":["Immunization With Mycobacterium tuberculosis Antigens Encapsulated in Phosphatidylserine Liposomes Improves Protection Afforded by BCG"],"prefix":"10.3389","volume":"10","author":[{"given":"Gil R.","family":"Diogo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Hart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alastair","family":"Copland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi-Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andy C.","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noemi","family":"Poerio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahavir","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Fraziano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajko","family":"Reljic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,6,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"S629","DOI":"10.1093\/infdis\/jix362","article-title":"What we know about tuberculosis transmission: an overview","volume":"216","author":"Churchyard","year":"2017","journal-title":"J Infect Dis."},{"key":"B2","doi-asserted-by":"publisher","first-page":"e1002607","DOI":"10.1371\/journal.ppat.1002607","article-title":"Vaccines against tuberculosis: where are we and where do we need to go?","volume":"8","author":"Ottenhoff","year":"2012","journal-title":"PLoS Pathog."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1016\/S0140-6736(05)67145-0","article-title":"Effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: the BCG-REVAC cluster-randomised trial","volume":"366","author":"Rodrigues","year":"2005","journal-title":"Lancet."},{"key":"B4","doi-asserted-by":"publisher","first-page":"c671","DOI":"10.1136\/bmj.c671","article-title":"Effect of revaccination with BCG in early childhood on mortality: randomised trial in Guinea-Bissau","volume":"340","author":"Roth","year":"2010","journal-title":"BMJ."},{"key":"B5","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/0304-4165(81)90341-X","article-title":"In vivo fate of large unilamellar sphingomyelin-cholesterol liposomes after intraperitoneal and intravenous injection into rats","volume":"674","author":"Ellens","year":"1981","journal-title":"Biochim Biophys Acta"},{"key":"B6","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/0167-5699(90)90034-7","article-title":"Immunological adjuvants: a role for liposomes","volume":"11","author":"Gregoriadis","year":"1990","journal-title":"Immunol Today"},{"key":"B7","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1006\/immu.1994.1023","article-title":"Liposomes as carriers for vaccines","volume":"4","author":"Wassef","year":"1994","journal-title":"Immunomethods"},{"key":"B8","first-page":"693","article-title":"Cytokine-containing liposomes as vaccine adjuvants","volume":"7","author":"Lachman","year":"1996","journal-title":"Eur Cytokine Netw."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1086\/515698","article-title":"Regulation of interleukin-12 by interleukin-10, transforming growth factor-beta, tumor necrosis factor-alpha, and interferon-gamma in human monocytes infected with Mycobacterium tuberculosis H37Ra","volume":"178","author":"Fulton","year":"1998","journal-title":"J Infect Dis."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/S0264-410X(97)00015-7","article-title":"Immunogenicity and protectivity of a new liposomal hepatitis A vaccine","volume":"15","author":"Ambrosch","year":"1997","journal-title":"Vaccine"},{"key":"B11","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.4049\/jimmunol.160.8.3637","article-title":"Liposomal formulation of a self lymphoma antigen induces potent protective antitumor immunity","volume":"160","author":"Kwak","year":"1998","journal-title":"J Immunol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1126\/science.7809629","article-title":"A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules","volume":"267","author":"Kovacsovics-Bankowski","year":"1995","journal-title":"Science"},{"key":"B13","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/18038","article-title":"Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen","volume":"398","author":"Sigal","year":"1999","journal-title":"Nature"},{"key":"B14","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.4049\/jimmunol.148.7.2207","article-title":"Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages","volume":"148","author":"Fadok","year":"1992","journal-title":"J Immunol."},{"key":"B15","doi-asserted-by":"crossref","first-page":"11335","DOI":"10.1016\/S0021-9258(17)44422-X","article-title":"Insertion of fluorescent phosphatidylserine into the plasma membrane of red blood cells. Recognition by autologous macrophages","volume":"258","author":"Tanaka","year":"1983","journal-title":"J Biol Chem."},{"key":"B16","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/sj.cdd.4400817","article-title":"Phosphatidylserine, a death knell","volume":"8","author":"Schlegel","year":"2001","journal-title":"Cell Death Differ."},{"key":"B17","doi-asserted-by":"publisher","first-page":"e60068","DOI":"10.1371\/journal.pone.0060068","article-title":"Emulsified phosphatidylserine, simple and effective peptide carrier for induction of potent epitope-specific T cell responses","volume":"8","author":"Ichihashi","year":"2013","journal-title":"PLoS ONE"},{"key":"B18","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/nature06307","article-title":"Identification of Tim4 as a phosphatidylserine receptor","volume":"450","author":"Miyanishi","year":"2007","journal-title":"Nature"},{"key":"B19","doi-asserted-by":"publisher","first-page":"E1360","DOI":"10.1073\/pnas.1200484109","article-title":"Janus-faced liposomes enhance antimicrobial innate immune response in Mycobacterium tuberculosis infection","volume":"109","author":"Greco","year":"2012","journal-title":"Proc Natl Acad Sci USA."},{"key":"B20","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.ymthe.2017.12.016","article-title":"Nanoparticle-fusion protein complexes protect against Mycobacterium tuberculosis infection","volume":"26","author":"Hart","year":"2018","journal-title":"Mol Ther."},{"key":"B21","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3389\/fimmu.2018.00155","article-title":"The multirole of liposomes in therapy and prevention of infectious diseases","volume":"9","author":"Nisini","year":"2018","journal-title":"Front Immunol."},{"key":"B22","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1128\/IAI.58.6.1932-1936.1990","article-title":"Liposomes containing anti-idiotypic antibodies: an oral vaccine to induce protective secretory immune responses specific for pathogens of mucosal surfaces","volume":"58","author":"Jackson","year":"1990","journal-title":"Infect Immun."},{"key":"B23","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/978-1-4615-3410-5_21","article-title":"Liposomes and conjugate vaccines for antigen delivery and induction of mucosal immune responses","volume":"327","author":"Michalek","year":"1992","journal-title":"Adv Exp Med Biol."},{"key":"B24","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.4049\/jimmunol.157.5.2174","article-title":"Hapten-induced model of murine inflammatory bowel disease: mucosa immune responses and protection by tolerance","volume":"157","author":"Elson","year":"1996","journal-title":"J Immunol."},{"key":"B25","first-page":"1771","article-title":"Characterization of liposomes for oral vaccines","author":"Childers","year":"1987","journal-title":"Adv Exp Med Biol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1002\/wnan.131","article-title":"Topical and mucosal liposomes for vaccine delivery","volume":"3","author":"Romero","year":"2011","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1084\/jem.178.6.2249","article-title":"An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection","volume":"178","author":"Flynn","year":"1993","journal-title":"J Exp Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1089\/jir.2006.0103","article-title":"IFN-gamma therapy of tuberculosis and related infections","volume":"27","author":"Reljic","year":"2007","journal-title":"J Interferon Cytokine Res."},{"key":"B29","doi-asserted-by":"publisher","first-page":"e1002052","DOI":"10.1371\/journal.ppat.1002052","article-title":"A gamma interferon independent mechanism of CD4 T cell mediated control of M. tuberculosis infection in vivo","volume":"7","author":"Gallegos","year":"2011","journal-title":"PLoS Pathog"},{"key":"B30","doi-asserted-by":"publisher","first-page":"12434","DOI":"10.1073\/pnas.0703510104","article-title":"Poor correlation between BCG vaccination-induced T cell responses and protection against tuberculosis","volume":"104","author":"Mittrucker","year":"2007","journal-title":"Proc Natl Acad Sci USA."},{"key":"B31","doi-asserted-by":"publisher","first-page":"e1005667","DOI":"10.1371\/journal.ppat.1005667","article-title":"CD4 T cell-derived IFN-gamma plays a minimal role in control of pulmonary Mycobacterium tuberculosis infection and must be actively repressed by PD-1 to prevent lethal disease","volume":"12","author":"Sakai","year":"2016","journal-title":"PLoS Pathog."},{"key":"B32","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/mi.2011.7","article-title":"The role of IL-10 in immune regulation during M. tuberculosis infection","volume":"4","author":"Redford","year":"2011","journal-title":"Mucosal Immunol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"978","DOI":"10.4049\/jimmunol.165.2.978","article-title":"IL-10 converts human dendritic cells into macrophage-like cells with increased antibacterial activity against virulent Mycobacterium tuberculosis","volume":"165","author":"Fortsch","year":"2000","journal-title":"J Immunol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/ni1449","article-title":"IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge","volume":"8","author":"Khader","year":"2007","journal-title":"Nat Immunol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.4049\/jimmunol.166.3.1951","article-title":"A model to predict cell-mediated immune regulatory mechanisms during human infection with Mycobacterium tuberculosis","volume":"166","author":"Wigginton","year":"2001","journal-title":"J Immunol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"e1004603","DOI":"10.1371\/journal.ppat.1004603","article-title":"Variability in tuberculosis granuloma T cell responses exists, but a balance of pro- and anti-inflammatory cytokines is associated with sterilization","volume":"11","author":"Gideon","year":"2015","journal-title":"PLoS Pathog."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1038\/ni1207-1281","article-title":"IL-10 or not IL-10: that is the question","volume":"8","author":"Jankovic","year":"2007","journal-title":"Nat Immunol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"6353","DOI":"10.4049\/jimmunol.177.9.6353","article-title":"Mucosal administration of Ag85B-ESAT-6 protects against infection with Mycobacterium tuberculosis and boosts prior bacillus Calmette-Guerin immunity","volume":"177","author":"Dietrich","year":"2006","journal-title":"J Immunol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1016\/j.vaccine.2010.12.135","article-title":"Ag85B-ESAT-6 adjuvanted with IC31(R) promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in volunteers with previous BCG vaccination or tuberculosis infection","volume":"29","author":"Van Dissel","year":"2011","journal-title":"Vaccine"},{"key":"B40","doi-asserted-by":"publisher","first-page":"10961","DOI":"10.1073\/pnas.0801496105","article-title":"ESAT-6-specific CD4 T cell responses to aerosol Mycobacterium tuberculosis infection are initiated in the mediastinal lymph nodes","volume":"105","author":"Reiley","year":"2008","journal-title":"Proc Natl Acad Sci USA."},{"key":"B41","doi-asserted-by":"publisher","first-page":"e01686","DOI":"10.1128\/mBio.01686-16","article-title":"Mucosal BCG vaccination induces protective lung-resident memory T cell populations against tuberculosis","volume":"7","author":"Perdomo","year":"2016","journal-title":"MBio"},{"key":"B42","doi-asserted-by":"publisher","first-page":"h4067","DOI":"10.1136\/bmj.h4067","article-title":"European medicines agency approves first malaria vaccine","volume":"351","author":"Hawkes","year":"2015","journal-title":"BMJ"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1038\/nbt1015-1015","article-title":"Landmark green light for Mosquirix malaria vaccine","volume":"33","author":"Morrison","year":"2015","journal-title":"Nat Biotechnol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.tube.2006.01.024","article-title":"RUTI: a new chance to shorten the treatment of latent tuberculosis infection","volume":"86","author":"Cardona","year":"2006","journal-title":"Tuberculosis."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.01349\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T11:24:21Z","timestamp":1694949861000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.01349\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,12]]},"references-count":44,"alternative-id":["10.3389\/fimmu.2019.01349"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.01349","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,12]]},"article-number":"1349"}}